Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals

Journal of Endocrinological Investigation

Volumn 34, Issue 1, 2011, Pages 21-25

  Peti, A ^a   Juhasz, A ^b   Kenyeres, P ^c   Varga, Z ^b   Seres, I ^b   Kovacs, G L ^a,d   Paragh, G ^b   Bajnok, L ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d MEDIPOLIS Knowledge Center   (Hungary)

Author keywords

Adiponectin; Homeostasis model assessment; Insulin resistance; Interleukin 6; Leptin; Non esterified fatty acid; Obesity; Resistin; Tumor necrosis factor

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; WAIST CIRCUMFERENCE;

ADIPOKINES; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; ESTERIFICATION; FATTY ACIDS; FEMALE; HEALTH; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 79955413687     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7025     Document Type: Article

References (36)

1. Staiger H, Häring HU. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes 2005, 113: 67-79.
2. Yudkin JS. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 2007, 39: 707-9. (Pubitemid 350099816)
3. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 2002, 5: 377-83. (Pubitemid 40684658)
4. Koutsari C, Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 2006, 47: 1643-50.
5. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-5. (Pubitemid 32472900)
6. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002, 103: 137-42.
7. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83. (Pubitemid 29299050)
8. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002, 147: 173-80.
9. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20: 1595-9. (Pubitemid 30353893)
10. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999, 130: 671-80. (Pubitemid 29196202)
11. Matsubara M, Katayose S, Maruoka S. Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol 2003, 148: 343-50. (Pubitemid 36410720)
12. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941-6. (Pubitemid 32756432)
13. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109: 1345-50. (Pubitemid 34546899)
14. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005, 126: 121-9. (Pubitemid 40726256)
15. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003, 111: 225-30. (Pubitemid 36105921)
16. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111: 932-9. (Pubitemid 40279897)
17. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003, 11: 997-1001. (Pubitemid 41137512)
18. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003, 88: 4848-56. (Pubitemid 37357535)
19. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003, 88: 5452-5. (Pubitemid 37452753)
20. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy U. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003, 149: 331-5. (Pubitemid 37304704)
21. Chen CC, Li TC, Li CI, Liu CS, Wang HJ, Lin CC. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005, 54: 471-5.
22. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366: 1059-62.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9. (Pubitemid 15018832)
24. Glund S, Krook A. Role of interleukin-6 signaling in glucose and lipid metabolism. Acta Physiol (Oxf) 2008, 192: 37-48. (Pubitemid 350265360)
25. Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 2008, 9: 20-9. (Pubitemid 350264626)
26. Spangenburg EE. Point, counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007, 102: 820. (Pubitemid 46220916)
27. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366: 1640-9.
28. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23: 57-63. (Pubitemid 30022895)
29. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46: 459-69. (Pubitemid 36577787)
30. Filippatos TD, Derdemezis CS, Gazi IF, et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest 2008, 38: 71-2. (Pubitemid 350293863)
31. Oki K, Yamane K, Kamei N, Nojima H, Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 2007, 67: 796-800. (Pubitemid 47628470)
32. Pfützner A, Hanefeld M, Lübben G, et al. Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk - results from the PIOSTAT study. Horm Metab Res 2007, 39: 764-8. (Pubitemid 350099826)
33. Chen CC, Li TC, Li CI, et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metabolism 2007, 56: 1216-20.
34. Kowalska I, Straczkowski M, Adamska A, et al. Serum retinol binding protein 4 is related to insulin resistance and non-oxidative glucose metabolism in lean and obese women with normal glucose tolerance. J Clin Endocrinol Metab 2008, 93: 2786-9. (Pubitemid 352008552)
35. Promintzer M, Krebs M, Todoric J, et al. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 2007, 92: 4306-12. (Pubitemid 350074749)
36. Silha JV, Nyomba BL, Leslie WD, Murphy U. Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care 2007, 30: 286-91. (Pubitemid 46198332)